Viatris is a pharmaceutical company based in Canonsburg, Penn. It formed in 2020 through a merger between Mylan and Upjohn, Pfizer’s off-patent medicine division. The company creates brand and generic drugs for infectious diseases and non-communicable diseases. Its portfolio of medications include Viagra, Xanax, and Lipitor. Viatris beat analyst expectations with reported sales of $4.4 billion in its first quarterly earnings report. Lipitor, which is used to treat high cholesterol, and Norvasc, which is used to treat high blood pressure, led in sales with $464.6 million and $227.7 million, respectively. The company employs around 45,000 people worldwide and has 50 manufacturing plants that produce oral solid doses, injectables, and active pharmaceutical ingredients.